Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat
- 30 August 2005
- Vol. 38 (1) , 74-84
- https://doi.org/10.1016/j.bone.2005.07.008
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- ΔFosB Induces Osteosclerosis and Decreases Adipogenesis by Two Independent Cell-Autonomous MechanismsMolecular and Cellular Biology, 2004
- Tail Suspension Induces Bone Loss in Skeletally Mature Mice in the C57BL/6J Strain but Not in the C3H/HeJ StrainJournal of Bone and Mineral Research, 2003
- Thiazolidinediones in Type 2 Diabetes MellitusDrugs, 2003
- A rat resistance exercise regimen attenuates losses of musculoskeletal mass during hindlimb suspensionActa Physiologica Scandinavica, 2002
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Glitazones: clinical effects and molecular mechanismsAnnals of Medicine, 2002
- NetoglitazoneDrugs of the Future, 2002
- PioglitazoneDrugs, 2000
- Association of Bone Mineral Density with a Polymorphism of the Peroxisome Proliferator-Activated Receptor γ Gene: PPARγ Expression in OsteoblastsBiochemical and Biophysical Research Communications, 1999
- Quantification of Bone Microarchitecture with the Structure Model IndexComputer Methods in Biomechanics and Biomedical Engineering, 1997